학술논문
Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection.
Document Type
Correction Notice
Author
Source
Subject
*DRUG development
*ORAL medication
*HEPATITIS C treatment
*
*
Language
ISSN
0022-2623